These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 12455724

  • 1. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
    Usberti M, Gerardi G, Micheli A, Tira P, Bufano G, Gaggia P, Movilli E, Cancarini GC, De Marinis S, D'Avolio G, Broccoli R, Manganoni A, Albertin A, Di Lorenzo D.
    J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
    [Abstract] [Full Text] [Related]

  • 2. [Influence of vitamin E and N-acetylcysteine on intracellular oxidative stress in T lymphocytes in children treated with dialysis].
    Zaniew M, Zachwieja J, Warzywoda A, Stefaniak E, Runowski D, Lewandowska-Stachowiak M.
    Wiad Lek; 2005; 58 Suppl 1():58-65. PubMed ID: 16060087
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 5. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
    Stefanovic V, Mitić-Zlatkovic M, Radivojevic J, Vlahovic P.
    Ren Fail; 2005 Apr; 27(3):283-8. PubMed ID: 15957544
    [Abstract] [Full Text] [Related]

  • 6. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, Bernabini G, Daini R, Casani A, Angelini D, Parrini M, Rossi A, Petrone I, Barsotti G, Donadio C, Donati G, Grazi G, Manca Rizza G, Garosi G, Sansoni E, Braccagni B, Sidoti A, Boracelli D, Biagioli M, Moriconi L, Finato V, Mannarino A, Grimaldi C, Pansa F, Imperiali P, Mura C, Bianchi S, Bigazzi R.
    Blood Purif; 2011 Apr; 32(1):7-14. PubMed ID: 21242686
    [Abstract] [Full Text] [Related]

  • 7. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients.
    Usberti M, Gerardi G, Bufano G, Tira P, Micheli A, Albertini A, Floridi A, Di Lorenzo D, Galli F.
    Am J Kidney Dis; 2002 Sep; 40(3):590-9. PubMed ID: 12200812
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
    Westhuyzen J, Saltissi D, Stanbury V.
    Ann Clin Lab Sci; 2003 Sep; 33(1):3-10. PubMed ID: 12661892
    [Abstract] [Full Text] [Related]

  • 9. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A.
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [Abstract] [Full Text] [Related]

  • 10. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B.
    Ren Fail; 2005 Jan; 27(4):367-72. PubMed ID: 16060121
    [Abstract] [Full Text] [Related]

  • 11. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients.
    Usberti M, Lima G, Arisi M, Bufano G, D'Avanzo L, Gazzotti RM.
    J Nephrol; 1997 Jan; 10(5):261-5. PubMed ID: 9364318
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in hemodialysis patients: a pilot study.
    Andrulli S, Di Filippo S, Manzoni C, Stefanelli L, Floridi A, Galli F, Locatelli F.
    Nephron Clin Pract; 2010 Jan; 115(1):c82-9. PubMed ID: 20215781
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S, Nasini MG, Santoni O, Tirotta A, Sanna A.
    ASAIO J; 1997 Jan; 43(5):M535-8. PubMed ID: 9360100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Varying intervals of subcutaneous epoetin alfa in hemodialysis patients.
    Beshara S, Bàràny P, Gutierrez A, Wikstrom B, Swedish Investigators Group.
    J Nephrol; 2004 Jan; 17(4):525-30. PubMed ID: 15372414
    [Abstract] [Full Text] [Related]

  • 18. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC.
    Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
    [Abstract] [Full Text] [Related]

  • 19. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Apr; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.